December 9, 2025
1 min read

Its future still in limbo, CSL Seqirus debuts $1B flu shot, antivenom plant in Australia

CSL, which earlier this year shelved plans to put its CSL Seqirus vaccine division up for sale, has opened the doors to a new $1 billion cell-based flu shot and antivenom facility in Melbourne.

Leave a Reply

Your email address will not be published.

Previous Story

Danone named first official yogurt and plant-based beverages sponsor at US Big Ten Conference

Next Story

What is quinoa? And is it actually good for you?

Previous Story

Danone named first official yogurt and plant-based beverages sponsor at US Big Ten Conference

Next Story

What is quinoa? And is it actually good for you?

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop